Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PYRAZINAMIDE Cause Eosinophil count increased? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Eosinophil count increased have been filed in association with PYRAZINAMIDE (Pyrazinamide). This represents 0.2% of all adverse event reports for PYRAZINAMIDE.

13
Reports of Eosinophil count increased with PYRAZINAMIDE
0.2%
of all PYRAZINAMIDE reports
0
Deaths
11
Hospitalizations

How Dangerous Is Eosinophil count increased From PYRAZINAMIDE?

Of the 13 reports, 11 (84.6%) required hospitalization, and 1 (7.7%) were considered life-threatening.

Is Eosinophil count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PYRAZINAMIDE. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does PYRAZINAMIDE Cause?

Drug-induced liver injury (588) Drug reaction with eosinophilia and systemic symptoms (492) Paradoxical drug reaction (407) Vomiting (307) Pyrexia (301) Drug ineffective (298) Off label use (288) Hepatotoxicity (279) Drug resistance (269) Nausea (251)

What Other Drugs Cause Eosinophil count increased?

ALBUTEROL (1,359) PREDNISONE (846) BUDESONIDE\FORMOTEROL (719) DUPILUMAB (712) TIOTROPIUM (682) MEPOLIZUMAB (670) MONTELUKAST (504) BUDESONIDE (493) CLOZAPINE (475) FLUTICASONE\SALMETEROL (416)

Which PYRAZINAMIDE Alternatives Have Lower Eosinophil count increased Risk?

PYRAZINAMIDE vs PYRIDOSTIGMINE PYRAZINAMIDE vs PYRIDOXINE PYRAZINAMIDE vs PYRIDOXINE\THIAMINE PYRAZINAMIDE vs PYRIMETHAMINE PYRAZINAMIDE vs PYROTINIB

Related Pages

PYRAZINAMIDE Full Profile All Eosinophil count increased Reports All Drugs Causing Eosinophil count increased PYRAZINAMIDE Demographics